title: [Salvage radiotherapy in rising PSA after radical prostatectomy].
abstract: Salvage radiotherapy after radical prostatectomy can be delivered either in case of biochemical recurrence or in situation of clinical relapse. In this last case, results are poor regarding disease-free survival but quite interesting regarding the local control rate. The best situation for salvage radiotherapy is still the rising PSA case: half of the patients can be in complete remission at 5 years after 65 Gy radiotherapy. The role of hormone therapy combined with salvage radiotherapy is still under investigation.
authors.affiliation: Département de Radiothérapie, Centre Léon-Bérard, 28, rue Laënnec, 69008, Lyon, France. carrie@lyon.fnclcc.fr
authors.forename: C
authors.initials: C
authors.lastname: Carrie
authors.forename: P
authors.initials: P
authors.lastname: Pommier
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local; D018579:Patient Selection; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery*; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D016879:Salvage Therapy; D013997:Time Factors
chemical_list: D018931:Antineoplastic Agents, Hormonal; D017430:Prostate-Specific Antigen